$RXMD Much of this additional interest has been driven by the Company’s ensuing conference call discussion, which focused on Progressive Care’s broader strategic realignment toward a scalable model with national reach, including its coming transformation from a pharmacy model to a comprehensive health services model that includes significant expansion in products and services, including RXMD Therapeutics branded products in the CBD and nutraceutical space, as well as a defining expansion into the Telehealth marketplace.
“As we scale up our current model and target significant new strategic initiatives in the coming months, we feel a duty to our shareholders to ensure both transparency and visibility are elevated to a commensurate degree,” stated S. Parikh Mars, Progressive Care CEO. “We have a potent message and a great story, and it is our responsibility to implement a strategy that communicates that story to our shareholders and the wider investment community.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.